MENU
+Compare
GDTC
Stock ticker: NASDAQ
AS OF
Apr 3, 02:54 PM (EDT)
Price
$2.40
Change
+$0.16 (+7.17%)
Capitalization
25.76M

GDTC CytoMed Therapeutics Limited Forecast, Technical & Fundamental Analysis

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers... Show more

GDTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for GDTC with price predictions
Apr 02, 2025

GDTC in downward trend: price dove below 50-day moving average on March 25, 2025

GDTC moved below its 50-day moving average on March 25, 2025 date and that indicates a change from an upward trend to a downward trend. In of 25 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GDTC as a result. In of 36 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GDTC turned negative on March 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 17 similar instances when the indicator turned negative. In of the 17 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for GDTC crossed bearishly below the 50-day moving average on March 13, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 6 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GDTC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for GDTC entered a downward trend on April 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where GDTC's RSI Indicator exited the oversold zone, of 7 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GDTC advanced for three days, in of 83 cases, the price rose further within the following month. The odds of a continued upward trend are .

GDTC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.406) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.036).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GDTC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GDTC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
GDTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GDTC is expected to report earnings to -3 cents per share on May 05

CytoMed Therapeutics Limited GDTC Stock Earnings Reports
Q4'24
Est.
$-0.04
Q3'24
Est.
$-0.04
Q2'24
Beat
by $0.01
Q1'24
Est.
$-0.04
Q4'23
Est.
$-0.05
The last earnings report on November 27 showed earnings per share of -3 cents, meeting the estimate of -3 cents. With 7.30K shares outstanding, the current market capitalization sits at 25.76M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Commonwealth Lane
Phone
+65 62507738
Employees
28
Web
https://w2.cytomed.sg
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SONM3.200.24
+8.11%
Sonim Technologies Inc.
SEI22.891.71
+8.07%
Solaris Energy Infrastructure Inc
SCSC34.250.46
+1.36%
ScanSource
ROK260.862.12
+0.82%
Rockwell Automation
BRZE36.30-0.07
-0.19%
Braze

GDTC and Stocks

Correlation & Price change

A.I.dvisor tells us that GDTC and CYCN have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GDTC and CYCN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
+1.48%
CYCN - GDTC
31%
Poorly correlated
+2.76%
CVKD - GDTC
29%
Poorly correlated
+1.20%
ADIL - GDTC
27%
Poorly correlated
+5.18%
JSPR - GDTC
26%
Poorly correlated
+2.17%
QSI - GDTC
26%
Poorly correlated
+2.50%
More